Introduction
Methods
Study design and settings
Study participants
Outcome
Data measurement, collection, and handling of missing data
Statistical analysis
Patient characteristics and in-hospital information
Main analysis
Prediction model derivation and validation using the Osaka-CRITICAL database
Outcome evaluation using the SG-PAROS database
Sensitivity analysis
Results
Study flowchart and patient characteristics
Characteristic | Osaka-CRITICAL 2012-2017 Derivation (N = 885) | Osaka-CRITICAL 2018-2019 Validation (N = 370) | SG-PAROS 2010-2016 (N = 1789) |
---|---|---|---|
Men | 750 (85%) | 327 (88%) | 1546 (86%) |
Age (years) | 61 (50, 68) | 60 (48, 68) | 57 (50, 65) |
Witnessed | 693 (78%) | 300 (81%) | 1373 (77%) |
Bystander CPR | 419 (47%) | 215 (58%) | 988 (55%) |
Bystander AED | 46 (5.2%) | 33 (8.9%) | 143 (8.0%) |
Prehospital Airway | |||
Intubation | 218 (25%) | 81 (22%) | 11 (0.6%) |
Supraglottic Airway | 331 (37%) | 120 (32%) | 1557 (87%) |
None | 336 (38%) | 169 (46%) | 221 (12%) |
Prehospital Drug | 245 (28%) | 122 (33%) | 1072 (60%) |
Prehospital ROSC | 296 (33%) | 153 (41%) | 365 (20%) |
Time to ED arrival (min) | 30 (24, 39) | 31 (26, 36) | 35 (30, 40) |
Cardiac rhythm on ED arrival | |||
Shockable | 300 (34%) | 136 (37%) | 554 (31%) |
Nonshockable | 361 (41%) | 136 (37%) | 915 (51%) |
ROSC | 224 (25%) | 98 (26%) | 320 (18%) |
In-hospital procedure | |||
ECMO | 307 (35%) | 150 (41%) | 10 (0.6%) |
PCI | 264 (30%) | 127 (34%) | 309 (17%) |
TTM | 367 (41%) | 153 (41%) | 203 (11%) |
Osaka-CRITICAL 2012-2017 (Derivation cohort) | SG-PAROS 2010-2016 | |||||
---|---|---|---|---|---|---|
Characteristic | ROSC N = 224 | Shockable N = 300 | Nonshockable N = 361 | ROSC N = 320 | Shockable N = 554 | Nonshockable N = 915 |
Men | 191 (85%) | 259 (86%) | 300 (83%) | 271 (85%) | 484 (87%) | 791 (86%) |
Age (years) | 60 (49, 67) | 61 (50, 67) | 62 (51, 69) | 56 (48, 64) | 57 (50, 64) | 58 (50, 65) |
Witness | 184 (82%) | 237 (79%) | 272 (75%) | 259 (81%) | 443 (80%) | 671 (73%) |
Bystander CPR | 119 (53%) | 141 (47%) | 159 (44%) | 192 (60%) | 293 (53%) | 503 (55%) |
Bystander AED | 15 (6.7%) | 20 (6.7%) | 11 (3.0%) | 45 (14%) | 22 (4.0%) | 76 (8.3%) |
Prehospital Airway | ||||||
Intubation | 34 (15%) | 86 (29%) | 94 (26%) | 2 (0.6%) | 1 (0.2%) | 8 (0.9%) |
SGA | 60 (27%) | 92 (31%) | 185 (51%) | 191 (60%) | 518 (94%) | 848 (93%) |
None | 130 (58%) | 122 (41%) | 82 (23%) | 127 (40%) | 35 (6.3%) | 59 (6.4%) |
Prehospital Drug | 38 (17%) | 113 (38%) | 94 (26%) | 115 (36%) | 409 (74%) | 548 (60%) |
Prehospital ROSC | 213 (95%) | 50 (17%) | 33 (9.1%) | 283 (88%) | 42 (7.6%) | 40 (4.4%) |
Time to ED arrival (min) | 29 (24, 38) | 30 (23, 37) | 32 (26, 40) | 34 (28, 39) | 34 (30, 40) | 35 (30, 40) |
In-hospital procedure | ||||||
ECMO | 17 (7.6%) | 179 (60%) | 111 (31%) | 3 (0.9%) | 5 (0.9%) | 2 (0.2%) |
PCI | 79 (35%) | 114 (38%) | 71 (20%) | 175 (55%) | 54 (9.7%) | 80 (8.7%) |
TTM | 149 (67%) | 129 (43%) | 89 (25%) | 104 (32%) | 44 (7.9%) | 55 (6.0%) |
Outcomes | ||||||
Admission | 223 (100%) | 220 (73%) | 186 (52%) | 307 (96%) | 117 (21%) | 185 (20%) |
Survival | 200 (89%) | 109 (36%) | 52 (14%) | 240 (75%) | 57 (10%) | 38 (4.2%) |
Good Neurological Outcome | 174 (78%) | 88 (29%) | 16 (4.4%) | 198 (62%) | 36 (6.5%) | 10 (1.1%) |
Osaka-CRITICAL 2012-2017 (Derivation cohort) | ||||
---|---|---|---|---|
Procedures | Total N = 629 | ROSC N = 223 | Shockable N = 220 | Nonshockable N = 186 |
PCI | 257 (41%) | 79 (35%) | 109 (50%) | 69 (37%) |
TTM | 365 (58%) | 149 (67%) | 127 (58%) | 89 (48%) |
ECMO | 272 (43%) | 17 (7.6%) | 160 (73%) | 95 (51%) |
SG-PAROS 2010-2016 | ||||
---|---|---|---|---|
Procedures | Total N = 609 | ROSC N = 307 | Shockable N = 117 | Nonshockable N = 185 |
PCI | 309 (51%) | 175 (57%) | 54 (46%) | 80 (43%) |
TTM | 199 (33%) | 104 (34%) | 41 (35%) | 54 (29%) |
ECMO | 7 (1.1%) | 3 (1.0%) | 3 (2.6%) | 1 (0.5%) |